Cargando…
Diagnosis and treatment of transthyretin‐related amyloidosis cardiomyopathy
Transthyretin‐related amyloidosis (ATTR) is a subgroup of amyloidosis that results from extracellular misassembled and toxic amyloid deposits affecting multiple organ systems, and cardiac tissues in particular. Because ATTR often presents as heart failure with preserved ejection fraction (HFpEF), it...
Autores principales: | Teng, Catherine, Li, Pengyang, Bae, Ju Young, Pan, Su, Dixon, Richard A. F., Liu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661658/ https://www.ncbi.nlm.nih.gov/pubmed/32725834 http://dx.doi.org/10.1002/clc.23434 |
Ejemplares similares
-
Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy
por: Asher, Clint, et al.
Publicado: (2022) -
Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022) -
Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
por: Yamamoto, Hiroyuki, et al.
Publicado: (2019) -
Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology
por: Skrahina, Volha, et al.
Publicado: (2021) -
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
por: Nativi-Nicolau, Jose, et al.
Publicado: (2021)